However, these complications developed late in the history of their disease, emphasising the need for continued screening.
Insulin-dependent diabetes mellitus (IDDM) is
a leading cause of legal blindness in people of working age. Duration of diabetes is a known risk factor for the development of retinopathy.1 It is unusual to find significant retinopathy within 10 years of diagnosis but 95% will develop background retinopathy within 15 years and up to 70% develop proliferative retinopathy within 30 years.z,3 However, there are patients with long-standing IDDM with little or no retinopathy. The reasons for this are unclear, although the recent Diabetes Control and Complications Trial (DCCT) has indicated the importance of good control in slowing the progression of retinopathy. 4 Other risk factors known to be important in the development of retinopathy include nephropathy and possibly hypertension. 5, 6 Pregnancy can also lead to a temporary worsening of retinopathy, perhaps in association with tight control?
The aims of the study were to identify patients with IDDM of 40 years or more duration and mild, minimal or no retinopathy and compare them with patients with IDDM of a similar duration who developed proliferative retinopathy. The principal objective was to identify any characteristics which may account for the relative sparing of ocular complications in these patients.
Materials and methods

Selection of patients
Fifty-two patients were recruited from a database of patients from the King's Diabetes Centre at King's College Hospital, London. The majority of patients in this study had been seen at the centre since diagnosis and medical notes were available from this time.
The inclusion criteria were patients with IDDM for 40 years or more. IDDM was defined as occurring in those in whom the diagnosis was made before age 30 years and insulin therapy commenced at onset or within 1 year of diagnosis.
A questionnaire was completed by the patient, a research nurse and ophthalmologist. Participants provided information on social and medical history, details of their diabetes including past and present insulin therapy, hospital admissions specifically for diabetic complications and treatment for retinal complications. In the majority of patients the medical notes were available to confirm the history given. Investigation included blood pressure measurement, urinalysis and blood was taken for creatinine levels, cholesterol and HbA le measurements. Results of urinalysis from two previous clinic visits were also recorded. The amount of albuminuria was quantified using the mean of at least two previous albumin:creatinine ratio measurements. All patients had an ocular examination consisting of visual acuity measurement, slit-lamp examination and fundoscopy following dilatation of the pupils. The group was then divided into those with minimal, mild or no retinopathy (group 1) and those who had documented proliferative retinopathy either in the past or at present (group 2). Statistical analysis was then performed. The Mann-Whitney test was used to compare the two groups for non-parametric data. Parametric data were compared using Student's t-test. Two-tailed p values are quoted.
Definitions
Minimal non-proliferative retinopathy was defined as fewer than three microaneurysms. Mild non-proliferative changes included microaneurysms, occasional intraretinal haemorrhage and hard exudates, and retinal oedema that did not encroach on the fovea.
Preproliferative retinopathy was defined as the presence of cotton wool spots, venous beading or loops and intraretinal microvascular abnormalities. Proliferative retinopathy was documented as the presence of neovascularisation either at the disc or elsewhere in the retina.
Microalbuminuria was defined as a negative Albustix measurement but an albumin-creatinine ratio of greater than 25 J-lg/mmol on at least two occasions. Proteinuria was defined as three consecutive positive Albustix measurements.
The number of cigarettes smoked was calculated as pack-years by multiplying the number of packs smoked per day (pack = 20 cigarettes) by the number of years over which that amount was smoked.
Group 2 (n = 23) The patients were divided into two groups depending on the retinal findings. Group 1 consists of 29 subjects. These patients had never had proliferative retinal complications. Group 2 consists of 23 subjects who had documented neovascularisation of the retina at some stage of their diabetes. The patients had been followed up at King's College Hospital for a mean of 45 years for group 1 and 40 years for group 2 ( Table 1) . Twenty-six patients (90%) from group 1 and 18 (78%) from group 2 have been seen in the department since their diagnosis. All the subjects were Caucasian. Fourteen (48%) patients from group 1 and 12 (55%) from group 2 had been smokers but only 3 patients in total still smoked. Tables 1  and 2 display the characteristics of the two groups obtained from the questionnaire and examination. Patients in group 1 who had not developed proliferative retinopathy were older (p = 0.02) and had a longer duration of IDDM (p = 0.03).
Ocular fe atures
At the time of examination 14 patients in the untreated group 1 had minimal or no retinopathy. The other 15 had mild retinopathy. In group 2, 9 patients had retinal neovascularisation, 12 had mild retinopathy and in 2 there was no view of the fundus due to cataract. Both of these last patients had documented neovascularisation in the past. The visual acuity in both groups was relatively well preserved. Twenty-seven patients (93%) in group 1 and 16 (70%) in group 2 had a visual acuity of at least 6/9 in one eye. Three patients were registered blind and 2 partially sighted. This was due to diabetes in 4 cases, all 
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p value calculated using the Mann-Whitney test. Abnormal creatinine values for group 1 = 330, group 2 = 205, 348,432. 
Diabetes
There was no significant difference between groups in the type of insulin that the patients were taking. All patients had originally used porcine-or bovine-derived insulin and had changed to a human insulin at some point during the course of their diabetes. Twenty-six patients (90%) from group 1 had a twice-daily regimen using two different types of insulin, compared with 13 (57%) in group 2 (p = 0.006). Ten patients (43°/,,) in group 2 had a three or four times daily insulin regimen.
The number of hospital admissions due to diabetes was low for both groups. Eight (28%) patients in group 1 and 4 (17%) in group 2 had no admissions. Nine (31 %) patients from group 1 and 11 from group 2 (48%) were taking hypotensive agents (p = 0.22), mduding 4 patients from group 1 and 9 from group 2 taking angiotensin converting emyzme inhibitors. There was no significant difference in mean diastolic or systolic blood pressures between the two groups. No patients were on lipid-lowering therapy but 4 commenced treatment following investigation undertaken as part of this study. There was no significant difference in any of the biochemical tests undertaken as part of the study.
Nephropathy
Twenty-five patients in group 1 (86%) and 18 in group 2 (78°/,, ) had three negative Albustix measurements and all these patients had a normal serum creatinine. Four (14%) of these patients from group 1 and 3 (13%) from group 2 had microalbuminuria determined from the measured albumin:creatinine ratio. Of those patients with positive Albustix measurements, 3 were in renal failure.
Discussion
The most striking feature of this group of long-term survivors with IDDM is the rarity of disabling retinal complications. Even in those who developed diabetic retinopathy requiring treatment the sight is relatively well preserved. Only 4 patients have visual impairment due to diabetes sufficient to qualify for blind or partial sight registration. This group of patients is, however, a 'survivor' group, and those with more serious retinopathy, blindness and other complications of diabetes may have died earlier in the course of their dis ase. In those patients who did develop proliferative diabetic retinopathy, treatment was initiated at a median of 35 years after diagnosis. Seventy-five per cent of group 2 commenced treatment more than 30 years after diagnosis, thereby representing a group with late-onset complications and emphasising the need for continued retinal screening even in these long-term patients. We examined in more detail those factors known to be associated with worsening of diabetic retinopathy. The importance of good blood glucose control in long-term IDDM patients without retinopathy has been evaluated over a 9 year follow-up period.s Despite medical notes being available in the majority of patients in our study, it is difficult to chart the blood glucose control over more than 40 years because for most of this period there have been no accurate tests reflecting long-term control.
Ninety per cent of the patients in group 1 with minimal or no retinal complications were on a twice daily regimen of insulin compared with 57% of group 2 (p = 0.006). This conventional regimen was shown in the DCCT4 to be less effective than more intensive insulin regimens in delaying the onset and slowing progression of diabetic retinopathy. Our results may reflect an attempt to improve glycaemic control following the development of retinal complications in group 2.
Nephropathy has been found to be important in the development of retinal complications and is also one of the major determinants of the prognosis of patients with IDDM.s,9 The majority of diabetics in our study, especially those without serious retinopathy (group I), were spared this complication. However, patients with serious nephropathy would have died at an earlier stage of their disease and are therefore selected out of our survivor cohort.
Long-term survivors with IDDM of more than 40 years' duration can be entirely free from retinopathy or show any minimal changes which have not progressed over many years. Proliferative changes had occurred in approximately half of our patients and they required treatment relatively late in the course of their disease, but overall suffer little visual disability. No significant demographic differences were found between those who did and did not develop serious retinopathy. However, this group of diabetic patients emphasises that continuing surveillance is required to detect treatable retinopathy even after several decades of IDDM.
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